The Vaccine Adjuvant Compendium (VAC) was launched in 2021 by the NIAID Division of Allergy, Immunology, and Transplantation (DAIT) to foster collaborations between NIAID-supported adjuvant researchers and the broader scientific community.
How To Use VAC
The VAC serves the following two communities:
- Vaccine researchers and developers: Access adjuvant metadata
- Adjuvant records in VAC list the points of contact for each adjuvant to allow vaccine researchers to contact the intellectual property (IP) holder directly.
- Adjuvant developers: Share your adjuvant metadata
- Adjuvant intellectual property (IP) holders interested in depositing information about an adjuvant in VAC should contact Vaccine Adjuvant Compendium (VAC) to establish a submitter account.
Exploring VAC
- You can search for adjuvants based on the following: keyword search; receptor of interest; immune profile; disease area/pathogen; and product grade.
- Each VAC record contains the following:
- Contact information for the IP-holder
- Vaccine Ontology ID: Each adjuvant in VAC is assigned a unique ID number (vaccine ontology ID) that links the VAC record to a corresponding entry in the Ontobee Vaccine ontology site; authors are encouraged to cite the Vaccine Ontology ID in publications
- Properties about the adjuvant, including chemical nature, receptor, mechanism of action, storage and stability characteristics, among others
- Preclinical use and associated publications
- Clinical use and associated publications
- Product Grade and Formulation(s)